Breast Cancer Clinical Trials

Showing 3681-3700 of 5,597 trials

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

NCT01065441

A Phase I/II study of an in-situ therapeutic cancer vaccine. Vaccines contain a source of antigen and and adjuvant. In this study the source of tumor antigen comes from the killing of a selected tumor by cryoablation (killing using extreme cold) and the adjuvant is intentionally mis-matched immune cells (AlloStim-TM) engineered to produce inflammatory cytokines.

Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more

Michael Har-Noy9 participantsStarted Dec 2010

Jerusalem, Israel

UNKNOWNPhase 1/2

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

NCT03994107

The purpose of this study is to evaluate the efficacy and safety of pegylated liposomal doxorubicin（PLD）plus Albumin-Bound Paclitaxel and trastuzumab as neoadjuvant therapy in HER-2 positive breast cancer.

Breast Cancer

Peking Union Medical College40 participantsStarted Oct 2019

Beijing, Beijing Municipality, China

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

Related Searches

A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.

Quell Opioid Reduction and Pain Relief in Patients With Cancer

A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.

Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Theory-based Training to Promote Breast Cancer Screening

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

Weight Gain Prevention for Breast Cancer Survivors

Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema

Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

IMpact of PRehabilitation in Oncology Via Exercise - Breast Cancer

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)